E2FBP1/DRIL1, an AT-rich interaction domain-family transcription factor, is regulated by p53

Molecular Cancer Research

Volumn 1, Issue 6, 2003, Pages 438-444

  Ma, Kaiwen ^a   Araki, Keigo ^a   Ichwan, Solachuddin J A ^a   Suganuma, Tamaki ^a   Tamamori Adachi, Mimi ^a   Ikeda, Masa Aki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; DOXORUBICIN; PROTEIN P53;

APOPTOSIS; ARTICLE; AT RICH SEQUENCE; BINDING SITE; CELL GROWTH; DNA DAMAGE; DRIL1 GENE; E2FBP1 GENE; GENE; GROWTH INHIBITION; HUMAN; HUMAN CELL; INTRON; PRIORITY JOURNAL; PROTEIN BINDING; REGULATORY MECHANISM; TUMOR SUPPRESSOR GENE; ULTRAVIOLET RADIATION;

AT RICH SEQUENCE; BASE SEQUENCE; CELL DIVISION; CELL LINE, TUMOR; CYCLIN D1; DNA DAMAGE; DNA-BINDING PROTEINS; HUMANS; INTRONS; MOLECULAR SEQUENCE DATA; ONCOGENES; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RNA, MESSENGER; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0037393673     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Suzuki, M., Okuyama, S., Okamoto, S., Shirasuna, K., Nakajima, T., Hachiya, T., Nojima, H., Sekiya, S., and Oda, K. A novel E2F binding protein with Myc-type HLH motif stimulates E2F-dependent transcription by forming a heterodimer. Oncogene, 17: 853-865, 1998.
2. Kortschak, R. D., Reimann, H., Zimmer, M., Eyre, H. J., Saint, R., and Jenne, D. E. The human dead ringer/bright homolog, DRIL1: cDNA cloning, gene structure, and mapping to D19S886, a marker on 19p13.3 that is strictly linked to the Peutz-Jeghers syndrome. Genomics, 51: 288-292, 1998.
3. Herrscher, R. F., Kaplan, M. H., Lelsz, D. L., Das, C., Scheuermann, R., and Tucker, R W. The immunoglobulin heavy-chain matrix-associating regions are bound by Bright: A B cell-specific trans-activator that describes a new DNA-binding protein family. Genes Dev., 9: 3067-3082, 1995.
4. Gregory, S. L., Kortschak, R. D., Kalionis, B., and Saint, R. Characterization of the dead finger gene identifies a novel, highly conserved family of sequence-specific DNA-binding proteins. Mol. Cell. Biol., 16: 792-799, 1996.
5. Kortschak, R. D., Tucker, P. W., and Saint, R. ARID proteins come in from the desert. Trends Biochem. Sci., 25: 294-299, 2000.
6. Zong, R., T., Das, C., and Tucker, P. W. Regulation of matrix attachment region-dependent, lymphocyte-restricted transcription through differential localization within promyelocytic leukemia nuclear bodies. EMBO J., 19: 4123-4133, 2000.
7. Kaplan, M. H., Zong, R. T., Herrscher, R. F., Scheuermann, R. H., and Tucker, P. W. Transcriptional activation by a matrix associating region-binding protein contextual requirements for the function of bright. J. Biol. Chem., 276: 21325-21330, 2001.
8. Webb, C. F., Smith, E. A., Medina, K. L., Buchanan, K. L., Smithson, G., and Dou, S. Expression of bright at two distinct stages of B lymphocyte development. J. Immunol., 160. 4747-4754, 1998.
9. Ko, L. J. and Prives, C. p53: puzzle and paradigm. Genes Dev., 10: 1054-1072, 1996.
10. el-Deiry, W. S. Regulation of p53 downstream genes. Semin. Cancer Biol., 8: 345-357, 1998.
11. Vogelstein, B., Lane, D., and Levine, A. J. Surfing the p53 network [news] [In Process Citation]. Nature, 408: 307-301, 2000.
12. Tanaka, H., Arakawa, H., Yamaguchi, T., Shiraishi, K., Fukuda, S., Matsui, K., Takei, Y., and Nakamura, Y. A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage. Nature, 404: 42-49, 2000.
13. Oda, K., Arakawa, H., Tanaka, T., Matsuda, K., Tanikawa, C., Mori, T., Nishimori, H., Tamai, K., Tokino, T., Nakamura, Y., and Taya, Y. p53AIPI, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell, 102: 849-862, 2000.
14. Mori, T., Anazawa, Y., Matsui, K., Fukuda, S., Nakamura, Y., and Arakawa, H. Cyclin K as a direct transcriptional target of the p53 tumor suppressor. Neoplasia, 4: 268-274, 2002.
15. Okamura, S., Arakawa, H., Tanaka, T., Nakanishi, H., Ng, C., C., Taya, Y., Monden, M., and Nakamura, Y. p53DINPI, a p53-inducible gene, regulates p53-dependent apoptosis. Mol. Cell, 8: 85-94, 2001.
16. el-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
17. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K., and Elledge, S. J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of GI cyclin-dependent kinases. Cell, 75: 805-816, 1993.
18. Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., and Beach, D. p21 is a universal inhibitor of cyclin kinases. Nature, 366: 701 - 704, 1993.
19. Polyak, K., Waldman, T., He, T. C., Kinzler, K. W., and Vogelstein, B. Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev., 10: 1945-1952, 1996.
20. Guo, A., Salomoni, P., Luo, J., Shih, A., Zhong, S., Gu, W., and Paolo Pandolfi, P. The function of PML in p53-dependent apoptosis [In Process Citation]. Nat. Cell Biol., 2: 730-736, 2000.
21. Fogal, V., Gostissa, M., Sandy, P., Zacchi, P., Stemsdorf, T., Jensen, K., Pandolfi, P., Will, H., Schneider, C., and Del Sal, G. Regulation of p53 activity in nuclear bodies by a specific PML isoform. EMBO J. 19: 6185 - 6195, 2000.
22. Shandala, T., Kortschak, R. D., Gregory, S., and Saint, R. The Drosophila dead ringer gene is required for early embryonic patterning through regulation of argos and buttonhead expression. Development, 126: 4341 -4349, 1999.
23. Valentine, S. A., Chen, G., Shandala, T., Fernandez, J., Mische, S., Saint, R., and Courey, A. J. Dorsal-mediated repression requires the formation of a multiprotein repression complex at the ventral silencer. Mol. Cell. Biol., 18: 6584-6594, 1998.
24. Peeper, D. S., Shvarts, A., Brummelkamp, T., Douma, S., Koh, E. Y., Daley, G. Q., and Bernards, R. A functional screen identifies hDRILI as an oncogene that rescues RAS-induced senescence. Nat. Cell Biol., 4: 148-153, 2002.
25. Dimri, G. P., Itahana, K., Acosta, M., and Campisi, J. Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14(ARF) tumor suppressor. Mol. Cell. Biol., 20: 273-285, 2000.
26. Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., and Lowe, S. W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p161NK4a. Cell, 88: 593-602, 1997.
27. Miyake, S., Makimura, M., Kanegae, Y., Harada, S., Sato, Y., Takamori, K., Tokuda, C., and Saito, I. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc. Natl. Acad. Sci. USA, 93: 1320-1324, 1996.
28. Nevins, J. R., DeGregori, J., Jakoi, L., and Leone, G. Functional analysis of E2F transcription factor. Methods Enzymol., 283: 205 - 219, 1997.
29. DeGregori, J., Kowalik, T., and Nevins, J. R. Cellular targets for activation by the E2FI transcription factor include DNA synthesis- and Gl/S-regulatory genes. Mol. Cell. Biol., 15: 4215-4224, 1995.
30. Ikeda, M. A., Jakoi, L., and Nevins, J. R. A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. Proc. Natl. Acad. Sci. USA, 93: 3215-3220, 1996.